Cargando…

Consensus Molecular Subtypes (CMS) in Metastatic Colorectal Cancer - Personalized Medicine Decision

BACKGROUND: Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these patients, but the survival rate has improved by treatment with novel systemic chemotherapy and targeted therapy in combination with surgery. New knowledg...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rebersek, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409603/ https://www.ncbi.nlm.nih.gov/pubmed/32463385 http://dx.doi.org/10.2478/raon-2020-0031

Ejemplares similares

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
por: Chowdhury, Saikat, et al.
Publicado: (2021)

MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
por: Amirkhah, Raheleh, et al.
Publicado: (2023)

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
por: Graham, Donna M., et al.
Publicado: (2016)

The Consensus Molecular Subtypes of Colorectal Cancer
por: Guinney, Justin, et al.
Publicado: (2015)

Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
por: Singh, Manish Pratap, et al.
Publicado: (2019)

Gut microbiome and its role in colorectal cancer
por: Rebersek, Martina
Publicado: (2021)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

Molecular Biomarkers and Histological Parameters Impact on Survival and Response to First- Line Systemic Therapy of Metastatic Colorectal Cancer Patients
por: Rebersek, Martina, et al.
Publicado: (2019)

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
por: Sirinukunwattana, Korsuk, et al.
Publicado: (2021)

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
por: Okita, Akira, et al.
Publicado: (2018)

YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes
por: Mouillet-Richard, Sophie, et al.
Publicado: (2020)

Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
por: Fontana, E, et al.
Publicado: (2019)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020)

Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
por: Purcell, Rachel V., et al.
Publicado: (2017)

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
por: González-Montero, Jaime, et al.
Publicado: (2023)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: ten Hoorn, Sanne, et al.
Publicado: (2021)

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2019)

Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets
por: Paz-Cabezas, Mateo, et al.
Publicado: (2022)

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
por: Valenzuela, Guillermo, et al.
Publicado: (2021)

Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer
por: Lu, Yujie, et al.
Publicado: (2023)

Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
por: Borelli, B., et al.
Publicado: (2021)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
por: Trinh, Anne, et al.
Publicado: (2018)

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
por: van den Bulk, Jitske, et al.
Publicado: (2019)

Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer
por: Nunez, Sha’Kayla K., et al.
Publicado: (2021)

The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
por: Tanjak, Pariyada, et al.
Publicado: (2023)

Identifying essential genes in genome-scale metabolic models of consensus molecular subtypes of colorectal cancer
por: Cheng, Chao-Ting, et al.
Publicado: (2023)

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience
por: Ocvirk, Janja, et al.
Publicado: (2016)

Personalized medicine in colorectal cancer
por: Vaseghi Maghvan, Padina, et al.
Publicado: (2020)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)

Molecular features and gene expression signature of metastatic colorectal cancer
por: Poturnajova, Martina, et al.
Publicado: (2021)

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial
por: Skof, Erik, et al.
Publicado: (2009)

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
por: Peters, Niek A., et al.
Publicado: (2022)

Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy
por: Yu, Irene S., et al.
Publicado: (2018)

CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
por: Yang, Mengyuan, et al.
Publicado: (2023)

Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline
por: Yu, Irene S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_446rktuf3j7g2orlablq43bkh2